KPF
ABBV icon

K2 Principal Fund’s AbbVie ABBV Stock Holding History

K2 Principal Fund’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-8,600
Closed -$625K – 305
2019
Q2 		$625K Buy
+8,600
New +$676K 0.08% 222
2015
Q3 		– Sell
-5,000
Closed -$336K – 158
2015
Q2 		$336K Sell
5,000
-94,400
-95% -$6.16M 0.06% 137
2015
Q1 		$5.82M Buy
99,400
+61,400
+162% +$3.71M 1.23% 21
2014
Q4 		$2.49M Buy
+38,000
New +$2.4M 0.58% 38

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

K2 Principal Fund's ABBV Position: Q3 2015 in Review

K2 Principal Fund sold out of AbbVie (ABBV) in Q3 2015, closing a stake of 14,022 shares — an estimated $942K sold.

K2 Principal Fund first reported a position in ABBV in Q4 2014 and held it in 2 quarters. The position peaked at $942K in Q2 2015. 1,604 funds tracked by Wall St. Rank hold ABBV as of Q3 2015.

  • K2 Principal Fund reported no remaining AbbVie position as of Q3 2015 after selling out during the quarter.
  • K2 Principal Fund sold 14,022 AbbVie shares in Q3 2015, an estimated $942K.
  • K2 Principal Fund first reported a position in AbbVie in Q4 2014 and held it in 2 quarters.
  • K2 Principal Fund's AbbVie position peaked at $942K in Q2 2015.
  • 1,604 funds tracked by Wall St. Rank held AbbVie as of Q3 2015.

Based on K2 Principal Fund's 13F filing for Q3 2015, filed 13 Nov 2015.